 |
|
Pneumococcal conjugate vaccines: choice of schedule and product development
Jin Lee
Clin Exp Pediatr. 2020;63(7):259-260. Published online 2020 Apr 27 DOI: https://doi.org/10.3345/cep.2019.01739
|
|
Citations to this article as recorded by
 Potential serotype-specific effectiveness against IPD of pneumococcal conjugate vaccines V114 and PCV20 in children given a 2+1 dosing regimen
Josiah Ryman, Jeffrey R. Sachs, Natalie Banniettis, Thomas Weiss, Maurice Ahsman, Ka Lai Yee, Jessica Weaver
Expert Review of Vaccines.2024; 23(1): 467. CrossRef
|